Information Journal Paper
APA:
Copy. (2017). Impact of muscarinic M3 receptor antagonism on the risk of type 2 diabetes in antidepressant-treated patients: A case-controlled study. CNS DRUGS, 31(6), 483-493. SID. https://sid.ir/paper/778043/en
Vancouver:
Copy. Impact of muscarinic M3 receptor antagonism on the risk of type 2 diabetes in antidepressant-treated patients: A case-controlled study. CNS DRUGS[Internet]. 2017;31(6):483-493. Available from: https://sid.ir/paper/778043/en
IEEE:
Copy, “Impact of muscarinic M3 receptor antagonism on the risk of type 2 diabetes in antidepressant-treated patients: A case-controlled study,” CNS DRUGS, vol. 31, no. 6, pp. 483–493, 2017, [Online]. Available: https://sid.ir/paper/778043/en